Intralesional autologous platelet rich plasma therapy in chronic nonhealing cutaneous ulcers: an interventional study from a tertiary care centre in North Kerala

Authors

  • V. P. K. Gopinath Department of Dermatology, MES Medical College, Malappuram, Kerala, India
  • V. M. Simi Department of Dermatology, MES Medical College, Malappuram, Kerala, India
  • K. Basheer Ahammed Department of Dermatology, MES Medical College, Malappuram, Kerala, India
  • P. M. Farisa Department of Dermatology, MES Medical College, Malappuram, Kerala, India
  • C. M. Ali Rishad Department of Dermatology, MES Medical College, Malappuram, Kerala, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20185080

Keywords:

Platelet rich plasma, PRP, Non healing ulcers, Growth factors

Abstract

Background: Treatment of chronic nonhealing cutaneous ulcers is a challenge to clinicians. When wounds fail to achieve sufficient healing after 4 weeks of conventional therapy reassess the underlying pathology and consider advanced therapeutic options. Autologous platelet rich plasma is a novel treatment for nonhealing cutaneous ulcers, which can provide growth factors directly onto the wound.

Methods: 34 patients with non-healing cutaneous ulcers satisfying inclusion and exclusion criteria were included in the study. All patients were treated with PRP therapy weekly for 6 weeks. Every week ulcer area and volume was measured and outcome expressed as improvement in area and volume of ulcers before and after PRP therapy.

Results: In our study majority were males (64%) and the mean age of population was 51.0±10.4 years. Of 34 patients 18 had venous ulcers. All ulcers healed within 12 weeks and mean duration of healing was 7.51±2.9 weeks. 8 (24.24%) patients had their ulcer completely healed within 6 weeks. Larger ulcers took long duration to heal and smaller ones healed within short duration. The total improvement in area and volume of ulcers was 85.7% and 90.7% (median) respectively at the end of 6 weeks.

Conclusions: PRP is an effective, safe, readily available and cheap outpatient procedure which can be widely used for the treatment of chronic recalcitrant ulcers which improves the quality of life and reduces the financial burden of patients. Further research and controlled, randomized prospective clinical trials on larger population are necessary to validate the results.

Author Biographies

V. P. K. Gopinath, Department of Dermatology, MES Medical College, Malappuram, Kerala, India

PROFESSOR AND HEAD OF THE DEPT.

DEPT. OF DERMATOLOGY

 MES MEDICAL COLLEGE

V. M. Simi, Department of Dermatology, MES Medical College, Malappuram, Kerala, India

ASSOCIATE PROFESSOR

DEPT OF DERMATOLOGY

MES MEDICAL COLLEGE

K. Basheer Ahammed, Department of Dermatology, MES Medical College, Malappuram, Kerala, India

ASSISTANT PROFESSOR

DEPT. OF DERMATOLOGY

MES MEDICAL COLLEGE

P. M. Farisa, Department of Dermatology, MES Medical College, Malappuram, Kerala, India

JUNIOR RESIDENT

DEPT. OF DERMATOLOGY

MES MEDICAL COLLEGE

C. M. Ali Rishad, Department of Dermatology, MES Medical College, Malappuram, Kerala, India

JUNIOR RESIDENT

DEPT OF DERMATOLOGY

MES MEDICAL COLLEGE

References

Kumar V, Abbas AK, Fausto N, Aster JC. Kumar: Robbins and Cotran Pathologic Basis of Disease, Professional Edition. 8th ed. 2009: 1464.

Schreml S, Szeimies R-M, Prantl L, Landthaler M, Babilas P. Wound healing in the 21st century. J Am Acad Dermatol. 2010;63(5):866–81.

Augustin M, Maier K. Psychosomatic Aspects of Chronic Wounds. Dermatology Psychosom/ Dermatologie und Psychosom. 2003;4(1):5–13.

Snyder RJ. Treatment of nonhealing ulcers with allografts. Clin Dermatol. 2005;23:388–95.

Taylor JE, Laity PR, Hicks J, Wong SS, Norris K, Khunkamchoo P, et al. Extent of iron pick-up in deforoxamine-coupled polyurethane materials for therapy of chronic wounds. Biomaterials. 2005;26(30):6024–33.

Gist S, Tio-Matos I, Falzgraf S, Cameron S, Beebe M. Wound care in the geriatric client. Clin Interventions Aging. 2009;4:269–87.

Edwards JV, Howley P, Cohen IK. In vitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings. Int J Pharm. 2004;284(1–2):1–12.

Schönfelder U, Abel M, Wiegand C, Klemm D, Elsner P, Hipler UC. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials. 2005;26(33):6664–73.

Suryanarayan S, Budamakuntala L, Sarvajnamurthy S. Efficacy of autologous platelet-rich plasma in the treatment of chronic nonhealing leg ulcers. J Plastic Aesthetic Res. 2014;1(2):65-9.

Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83(1):1–9.

Bhanot S, Alex JC. Current Applications of Platelet Gels in Facial Plastic Surgery. Facial Plast Surg. 2002;18(1):27–34.

Arnold T, Stanley J, Fellowes EP, Moncada GA, Allen R, Hutchinson JJ, et al. Prospective, multicenter study of managing lower extremity venous ulcers. Ann Vasc Surg. 1994;8(4):356-62.

Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum‑assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care. 2008;31:631‑6.

Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet‑derived wound healing factors (PDWHF). Ann Surg. 1986;204:322‑30.

Dionyssiou D, Demiri E, Foroglou P, Cheva A, Saratzis N, Aivazidis C, et al. The effectiveness of intralesional injection of platelet-rich plasma in accelerating the healing of chronic ulcers. An experimental and clinical study. Int Wound J. 2013;10(4):397-406.

Kumar SA, Binitha MP, Sarita S. A clinical and aetiological study of chronic leg ulcers. IJCMR. 2016;3(12):3438-40.

Bernuzzi G, Tardito S, Bussolati O, Adorni D, Cantarelli S, Fagnoni F, et al. Platelet gel in the treatment of cutaneous ulcers: The experience of the Immunohaematology and Transfusion Centre of Parma. Blood Transfus. 2010;8(4):237–47.

Sakata J1, Sasaki S, Handa K, Uchino T, Sasaki T, Higashita R, et al. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program. Ostomy Wound Manag. 2012;58(4):36-49.

Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Update in Cochrane Database Syst Rev. 2013;1:CD001737;23440784.

Wiechula R. The use of moist wound-healing dressings in the management of split-thickness skin graft donor sites: a systematic review. Int J Nurs Pract. 2003;9(2):9–17.

Fu X, Li X, Cheng B, Chen W, Sheng Z. Engineered growth factors and cutaneous wound healing: Success and possible questions in the past 10 years. Wound Repair Regeneration. 2005;13:122–30.

Hong JP, Kim YW, Jung HD, Jung K Il. The effect of various concentrations of human recombinant epidermal growth factor on split-thickness skin wounds. Int Wound J. 2006;3(2):123–30.

Nanney LB, Paulsen S, Davidson MK, Cardwell NL, Whitsitt JS, Davidson JM. Boosting epidermal growth factor receptor expression by gene gun transfection stimulates epidermal growth in vivo. Wound Repair Regen. 2000;8(2):117–27.

Jones V, Grey J, Harding K. ABC of wound healing: Wound dressings. Br Med J. 2006;332:777–80.

Cutting KF. Wound dressings : 21st century performance requirements. J Wound Care. 2010;19(1):4–9.

Van Rijswijk L. Full thickness leg ulcers: Patient demographics and predictors of healing. Multi-center Leg ulcer study Group. J Fam Pract. 1993;36(6):625-32.

Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004;30(2):145–51.

Steenvoorde P, van Doorn LP, Naves C, Oskam J. Use of autologous platelet-rich fibrin on hard-to-heal wounds. J Wound Care. 2008;17(2):60–3.

Downloads

Published

2019-01-25

Issue

Section

Original Research Articles